Comparative activities of clinafloxacin against gram-positive and -negative bacteria

被引:29
作者
Ednie, LM
Jacobs, MR
Appelbaum, PC
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA
[2] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
关键词
D O I
10.1128/AAC.42.5.1269
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Activities of clinafloxacin, ciprofloxacin, levofloxacin, sparfloxacin, trovafloxacin, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, ceftazidime, and imipenem against 354 ciprofloxacin-susceptible and -intermediate-resistant organisms were tested by agar dilution. Clinafloxacin yielded the lowest quinolone MICs (less than or equal to 0.5 mu g/ml against ciprofloxacin-susceptible organisms and less than or equal to 16.0 mu g/ml against ciprofloxacin-intermediate resistant organisms) compared to those of levofloxacin, trovafloxacin, and sparfloxacin. Ceftazidime, piperacillin alone or combined with tazobactam, trimethoprim-sulfamethoxazole, and imipenem usually yielded higher MICs against ciprofloxacin-resistant strains.
引用
收藏
页码:1269 / 1273
页数:5
相关论文
共 23 条
[1]  
[Anonymous], NCCLS PUBL
[2]  
Baquero F, 1996, J ANTIMICROB CHEMOTH, V37, P1
[3]   THE INVITRO ACTIVITY OF CEFTAZIDIME COMPARED WITH THAT OF OTHER CEPHALOSPORINS [J].
BINT, AJ ;
YEOMAN, P ;
KILBURN, P ;
ANDERSON, R ;
STANSFIELD, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :47-51
[4]   INVITRO ACTIVITY OF IMIPENEM - A REVIEW [J].
BRAVENY, I .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (05) :456-462
[5]   The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects [J].
Bron, NJ ;
Dorr, MB ;
Mant, TG ;
Webb, CL ;
Vassos, AB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) :1023-1029
[6]   In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin [J].
Cohen, MA ;
Huband, MD ;
Gage, JW ;
Yoder, SL ;
Roland, GE ;
Gracheck, SJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (02) :205-211
[7]   INVITRO ANTIBACTERIAL ACTIVITIES OF THE FLUOROQUINOLONES PD-117596, PD-124816, AND PD-127391 [J].
COHEN, MA ;
HUBAND, MD ;
MAILLOUX, GB ;
YODER, SL ;
ROLAND, GE ;
HEIFETZ, CL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1991, 14 (03) :245-258
[8]   EFFICACY OF QUINOLONES IN PREVENTING STAPHYLOCOCCUS AUREUS-INDUCED ABSCESS IN MICE [J].
COHEN, MA ;
GAGE, JW ;
HUBAND, MD ;
MESERVEY, MA ;
VANDERROEST, SR ;
YODER, SL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (03) :551-555
[9]   IN-VITRO AND IN-VIVO ACTIVITIES OF CLINAFLOXACIN, CI-990 (PD-131112), AND PD-138312 VERSUS ENTEROCOCCI [J].
COHEN, MA ;
YODER, SL ;
HUBAND, MD ;
ROLAND, GE ;
COURTNEY, CL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :2123-2127
[10]   CROSS-RESISTANCE ANALYSIS FOR CLINAFLOXACIN COMPARED WITH CIPROFLOXACIN, FLEROXACIN, OFLOXACIN, AND SPARFLOXACIN USING A PREDICTOR PANEL OF CIPROFLOXACIN-RESISTANT BACTERIA [J].
CORMICAN, MG ;
JONES, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (02) :431-434